Jean-Marc Bellemin
Director of Finance/CFO bij IOVANCE BIOTHERAPEUTICS, INC.
Vermogen: 868 096 $ op 31-03-2024
Actieve functies van Jean-Marc Bellemin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 11-03-2021 | - |
Director of Finance/CFO | 14-12-2020 | - | |
Treasurer | 14-12-2020 | - |
Loopbaan van Jean-Marc Bellemin
Eerdere bekende functies van Jean-Marc Bellemin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GRITSTONE BIO, INC. | Director of Finance/CFO | 01-01-2018 | 11-12-2020 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01-01-2008 | 01-12-2017 |
Opleiding van Jean-Marc Bellemin
Université Paris Dauphine-PSL | Undergraduate Degree |
ESSEC Business School | Masters Business Admin |
Université Paris II Panthéon Assas | Graduate Degree |
Statistieken
Internationaal
Frankrijk | 4 |
Verenigde Staten | 4 |
Operationeel
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoraal
Consumer Services | 4 |
Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
GRITSTONE BIO, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Beurs
- Insiders
- Jean-Marc Bellemin
- Ervaring